Harigai, R.; Sato, R.; Hirose, C.; Takenouchi, T.; Kosaki, K.; Hirose, T.; Saya, H.; Arima, Y.
Mutation of PTPN11 (Encoding SHP-2) Promotes MEK Activation and Malignant Progression in Neurofibromin-Deficient Cells in a Manner Sensitive to BRAP Mutation. Cancers 2022, 14, 2377.
https://doi.org/10.3390/cancers14102377
AMA Style
Harigai R, Sato R, Hirose C, Takenouchi T, Kosaki K, Hirose T, Saya H, Arima Y.
Mutation of PTPN11 (Encoding SHP-2) Promotes MEK Activation and Malignant Progression in Neurofibromin-Deficient Cells in a Manner Sensitive to BRAP Mutation. Cancers. 2022; 14(10):2377.
https://doi.org/10.3390/cancers14102377
Chicago/Turabian Style
Harigai, Ritsuko, Ryo Sato, Chikako Hirose, Toshiki Takenouchi, Kenjiro Kosaki, Takanori Hirose, Hideyuki Saya, and Yoshimi Arima.
2022. "Mutation of PTPN11 (Encoding SHP-2) Promotes MEK Activation and Malignant Progression in Neurofibromin-Deficient Cells in a Manner Sensitive to BRAP Mutation" Cancers 14, no. 10: 2377.
https://doi.org/10.3390/cancers14102377
APA Style
Harigai, R., Sato, R., Hirose, C., Takenouchi, T., Kosaki, K., Hirose, T., Saya, H., & Arima, Y.
(2022). Mutation of PTPN11 (Encoding SHP-2) Promotes MEK Activation and Malignant Progression in Neurofibromin-Deficient Cells in a Manner Sensitive to BRAP Mutation. Cancers, 14(10), 2377.
https://doi.org/10.3390/cancers14102377